$2.35 +0.03 (%) Rosetta Genomics Ltd - NASDAQ

Dec. 18, 2014 | 03:56 PM

Partner Headlines

  1. Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance

    GuruFocus | Nov. 18, 2014 | 11:04AM EST
  2. Rosetta Genomics' microRNA-Based Assay For Thyroid Cancer Highlighted In Poster Presentation At 84th Annual Meeting Of The American Thyroid Association

    Benzinga | Oct. 23, 2014 | 08:06AM EST
  3. Biocept And Rosetta Genomics Collaborate To Evaluate microRNAs From Circulating Tumor Cells

    Benzinga | Oct. 13, 2014 | 08:31AM EST
  4. Rosetta Genomics Announces Final New York State Approval for Rosetta Kidney Cancer Test

    Benzinga | Jul. 22, 2014 | 09:33AM EST
  5. UPDATE: Barrington Research Initiates Coverage On Rosetta Genomics Ltd. On Good Market Position

    Benzinga | Jun. 4, 2014 | 10:33AM EST
  6. Morning Market Movers

    Benzinga | Jan. 13, 2014 | 09:54AM EST
  7. Rosetta Genomics Reports Execution of Credentialing Deals with Two National Healthcare Preferred Provider Networks

    Benzinga | Sep. 9, 2013 | 08:36AM EST
  8. Rosetta Genomics Wins Two Key US Patent Allowances

    Benzinga | Feb. 14, 2013 | 01:35AM EST
  9. Rosetta Genomics Expands Management Team With CMO and CSO

    Benzinga | Oct. 11, 2012 | 03:48AM EST
  10. Benzinga's M&A Chatter for Thursday October 4, 2012

    Benzinga | Oct. 4, 2012 | 12:13PM EST
  11. Rosetta Genomics (ROSG) Up 5.5% After Announcing Business Update

    MarketIntelligenceCenter | Sep. 18, 2012 | 11:44AM EST
  12. Health Care Sector Wrap

    FoxBusiness | Aug. 29, 2012 | 10:45AM EST
  13. Rosetta Genomics Announces Exercise and Closing of Underwriter's Over-Allotment Option

    Benzinga | Aug. 29, 2012 | 06:04AM EST
  14. A Peek Into The Market Before The Trading Starts

    Benzinga | Aug. 3, 2012 | 01:15AM EST
  15. Rosetta Genomics Announces Pricing of Public Offering of 5.5 Million Ordinary Shares at $5/Share

    Benzinga | Aug. 3, 2012 | 00:46AM EST
  16. Six Flags Entertainment, Sanmina-SCI Corporation Among Stocks Gapping Up Tuesday

    FoxBusiness | Jul. 24, 2012 | 04:31AM EST
  17. Health Care Sector Wrap

    FoxBusiness | Jul. 10, 2012 | 10:47AM EST
  18. Rosetta Genomics (ROSG) Up 7.7% After NY Approval for Lung Cancer Test, Stock Sale

    MarketIntelligenceCenter | Jun. 26, 2012 | 13:33PM EST
  19. Rosetta Genomics Secures Reimbursement Pricing, Shares Surge 15%

    Benzinga | Jun. 19, 2012 | 04:16AM EST
  20. Rosetta Genomics Announces Compliance With Continued Listing Requirements of The NASDAQ Capital Market

    Benzinga | Jun. 6, 2012 | 01:32AM EST
  21. Genetic Technologies Executes Exclusive Distribution Agreement with Rosetta Genomics

    Benzinga | Jun. 1, 2012 | 07:04AM EST
  22. Data on Two of Rosetta Genomics' Launched Diagnostic Assays to Be Presented at ASCO 2012

    Benzinga | Jun. 1, 2012 | 02:18AM EST
  23. Rosetta Genomics Announces Study Validating miRview mets2 Published in The Oncologist

    Benzinga | May. 25, 2012 | 04:29AM EST
  24. From Earlier: Rosetta Genomics to Raise $6.6M in Registered Direct Offering

    Benzinga | May. 25, 2012 | 01:17AM EST
  25. Benzinga's Microcap Movers for Thursday May 24, 2012

    Benzinga | May. 25, 2012 | 01:13AM EST
  26. Rosetta Genomics (ROSG) Gains 124.2% as Runup Continues

    MarketIntelligenceCenter | May. 24, 2012 | 12:58PM EST
  27. Rosetta Genomics Surges, Shares Rise 1000% in 8 Trading Days

    Benzinga | May. 24, 2012 | 06:19AM EST
  28. From Earlier: Rosetta Genomics to Raise $2.2 Million in Registered Direct Offering

    Benzinga | May. 17, 2012 | 01:24AM EST
  29. Rosetta Genomics Announces One-for-Fifteen Reverse Stock Split

    Benzinga | May. 14, 2012 | 05:53AM EST
  30. Rosetta Announces $1.75 Million Debt Financing and Potential $1.25 Million Licensing Transaction

    Benzinga | Jan. 27, 2012 | 01:46AM EST
  31. Benzinga's Microcap Movers for Wednesday January 25, 2012

    Benzinga | Jan. 25, 2012 | 16:41PM EST
Trading Center